Lanreotide depot/autogel before, during, and after peptide receptor radionuclide therapy in advanced neuroendocrine tumors: data from the PRELUDE study (*)
Authors
Prasad, VSrirajaskanthan, R
Toumpanakis, C
Grana, C
Baldari, S
Shah, T
Lamarca, Angela
Courbon, F
Scheidhauer, K
Baudin, E
Thanh, X
Houchard, A
Bodei, L
Affiliation
Universitätsklinikum UlmIssue Date
2019